Sompraz%2525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a fixed-dose combination product containing **esomeprazole** (a proton pump inhibitor) and **amoxicillin** and **clarithromycin** (antibiotics). This combination is designed for the eradication of *Helicobacter pylori* (*H. pylori*). ## Primary Indications * Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease. ## Adult Dosing The typical adult regimen is one capsule taken twice daily for 10 days. The capsule contains: * Esomeprazole 20 mg * Amoxicillin 1000 mg * Clarithromycin 500 mg *Note: The provided description of "Sompraz%2525252525252525252525252525252525252525252525252525252525252525252520hp" may indicate a specific formulation or strength. Always confirm the exact components and strengths from the product packaging or formulary.* ## Pediatric Dosing Specific pediatric dosing for Sompraz HP is not established. Dosing for *H. pylori* eradication in children typically involves separate formulations and doses of esomeprazole, amoxicillin, and clarithromycin, often guided by specialized pediatric infectious disease or gastroenterology protocols. ## Dose Adjustments * **Renal Impairment:** No dose adjustment is typically required for esomeprazole or amoxicillin in mild to moderate renal impairment. Clarithromycin accumulation may occur in severe renal impairment (CrCl < 30 mL/min), and dose reduction may be considered. * **Hepatic Impairment:** In severe hepatic impairment, the dose of esomeprazole may need to be reduced. No specific dose adjustment for clarithromycin or amoxicillin is usually necessary in hepatic impairment unless severe. ## Contraindications * Hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or other proton pump inhibitors, penicillins, or macrolides. * History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. * Concomitant use with ergotamine or dihydroergotamine. * Patients with a history of *Clostridium difficile*-associated diarrhea with prior antibiotic use. * Severe renal or hepatic impairment (relative contraindication for clarithromycin). ## Adverse Effects Common adverse effects include: * **Gastrointestinal:** Diarrhea, nausea, abdominal pain, taste disturbances, vomiting. * **Headache** * **Rash** * **Allergic reactions** (including anaphylaxis) * **QTc prolongation** (especially with clarithromycin) * *Clostridium difficile*-associated diarrhea ## Key Drug Interactions * **CYP3A4 Inhibitors/Inducers:** Clarithromycin is a moderate inhibitor of CYP3A4. This can increase serum concentrations of drugs metabolized by CYP3A4 (e.g., certain statins, benzodiazepines, calcium channel blockers, warfarin). * **Warfarin:** May increase INR and risk of bleeding. * **Ketoconazole/Itraconazole:** Clarithromycin may decrease their absorption. * **Digoxin:** May increase serum digoxin levels. * **Methotrexate:** May increase methotrexate levels. * **Proton Pump Inhibitors:** Can decrease absorption of drugs requiring acidic environments (e.g., ketoconazole, iron salts). ## Monitoring * Monitor for signs and symptoms of allergic reactions. * Assess for gastrointestinal side effects, particularly *Clostridium difficile*-associated diarrhea. * Monitor INR if used concomitantly with warfarin. * Evaluate for therapeutic response and *H. pylori* eradication post-treatment (e.g., via urea breath test or stool antigen test). ## Clinical Pearls * This combination therapy is intended for short-term use (10 days) for *H. pylori* eradication. * Administer as prescribed to ensure adequate drug exposure for eradication. * Educate patients on the importance of completing the full course of therapy. * Advise patients to report any severe diarrhea, rash, or signs of allergic reaction promptly. * Consider potential for cross-reactivity in patients with penicillin allergy. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, product monographs, and relevant guidelines for complete and up-to-date drug information, including specific indications, contraindications, warnings, precautions, and adverse effects. Verify doses and regimens with local institutional protocols.